Skip to main content

D. E. Shaw & Co., Inc.

Position in PRGO — PERRIGO Co plc

CIK 1009207 New York, NY

Position in PRGO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,740,537
-$4,195,393 QoQ
Shares Held
348,281
-38.9% QoQ
Ownership
0.252%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PRGO Over Time

Shares Held

Position Value (USD)

Derivatives in PRGO

reported options exposure · as of Jun 30, 2022
CallValue
$3,424,108
CallShares
84,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $613,305,594 across 42 Drug Manufacturers - Specialty & Generic names. PRGO ranks #25 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRGO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,740,537 348,281
2025-12-31 $7,935,930 570,110
2025-09-30 $1,492,735 67,029
2024-09-30 $1,447,581 55,188
2024-06-30 $6,405,208 249,424
2023-09-30 $412,825 12,921
2022-06-30 $3,424,108 84,400
2022-06-30 $3,630,000 89,475
2022-03-31 $1,706,292 44,400
2022-03-31 $5,100,122 132,712
2021-09-30 $239,158 5,053
2021-06-30 $12,227,874 266,693
2021-03-31 $42,273,909 1,044,574
2020-12-31 $33,950,976 759,190
2020-09-30 $9,379,274 204,297
2020-06-30 $2,707,787 48,992
2020-06-30 $1,011,441 18,300
2020-06-30 $1,564,141 28,300
2020-03-31 $880,047 18,300